Find the latest oncology news for your sub-specialty area
Imaging agent illuminates lung cancer tumours
Surgery, especially surgery to remove cancerous tumours, relies on a range of tools and techniques…
Browsing: Clinical Focus
Researchers identify hormone that drives fatigue after cancer radiation therapy
Fatigue is a common and potentially debilitating side effect of cancer radiation therapy. A team…
Concentration of surgery has improved operations for childhood cancer
Neuroblastoma is a tumour of the sympathetic nervous system that occurs mainly in young children. Every…
Why don’t T cells destroy solid tumours during immunotherapy?
The great hope of cancer immunotherapy is to bolster our own immune cells in specific…
Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients
Cambridge scientists have managed to identify and kill those breast cancer cells that evade standard…
ASH 2022: Striving to improve treatment options for acute myeloid leukaemia
If there is one thing a cancer patient wants beyond fast, effective treatment – it…
ASH 2022: Novel drug shows early promise in treating multiple myeloma
A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma,…
ASH 2022: New data for talquetamab, a first-in-class GPRC5DxCD3 bispecific antibody, suggesting durable responses in patients with heavily pretreated multiple myeloma
Results have been announced for the Phase 1/2 MonumenTAL-1 study of talquetamab, an investigational, off-the-shelf…
ASH 2022: Older or high-risk patients with newly diagnosed AML respond well to triplet therapy
Researchers observed encouraging response rates in older or high-risk patients with newly diagnosed acute myeloid…
ASH 2022: Chemotherapy-free regimen ponatinib plus blinatumomab effective in patients with newly diagnosed Ph+ ALL
The chemotherapy-free regimen of ponatinib and blinatumomab achieved high response rates and reduced the need…